Furthermore, our data demonstrated a decrease in the Ki67 proliferating index in regrown tumors treated with PF-562271, suggesting that Pyk2 and FAK signaling has a strong influence on cell-cycle regulation and glioma cell proliferation. This evidence concerns the gene PTK2 and central nervous system cancer.